v3.25.2
Share-based benefits reserve
9 Months Ended
May 31, 2025
Share-Based Payment Arrangement [Abstract]  
Share-based benefits reserve

9. Share-based benefits reserve

 

The Company has a share option plan (the “Plan”) to attract, retain and motivate qualified directors, officers, employees and consultants whose present and future contributions are important to the success of the Company by offering them an opportunity to participate in the Company’s future performance through the award of share options.

 

Each share option converts into one common share of the Company on exercise. No amounts are paid or payable by the recipient on receipt of the option. The options carry neither rights to dividends nor voting rights. Options may be exercised at any time from the date of vesting to the date of their expiry.

 

In 2017, the Plan was amended such that the total number of common shares reserved and available for grant and issuance pursuant to the Plan is to equal 10% of the issued and outstanding common shares of the Company.

 

Options granted on June 14, 2021, vest over a 2-year period whereby 25% of the options granted vested on the date of grant, and the remaining unvested options vest in equal instalments every 6-months thereafter. The fair value of stock options granted was $1,317,155. A total stock-based compensation expense was recognized of $Nil for the nine months period ended May 31, 2025 (August 31, 2024 - $Nil).

 

The following reconciles the options outstanding at the beginning and end of the period that were granted to eligible participants pursuant to the Plan:

 

   May 31, 2025   August 31, 2024 
   Number of Options   Weighted Average Exercise Price   Number of Options   Weighted Average Exercise Price 
   #   $   #   $ 
Balance, beginning of period   565,689    3.61    565,689    3.72 
Forfeited during the period   -    -    -    - 
Balance as at period end   565,689    3.61    565,689    3.61 
Exercisable as at period end   565,689    3.61    565,689    3.61 

 

As at May 31, 2025, the options have no intrinsic value (August 31, 2024 – nil). As at May 31, 2025, all options are exercisable with a weighted average remaining life of 1.10years (August 31, 2024 – 1.8 years)

 

 

Pineapple Financial Inc.

Notes to the Condensed Interim Consolidated Financial Statements for period ended May 31, 2025 - Unaudited

(Expressed in US Dollars)